autologous skin graft

Cell therapyexperimental

Clinical trial activity

2 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Apr 30, 2007 (NCT00471939)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • autologous skin graft

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01555515Phase 1/Phase 2 (Phase 2)Mar 1, 2012Aevi Genomic Medicine, Tel Aviv University
NCT00471939Phase 2Apr 30, 2007Baxalta, Kuros Biosurgery AG
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Aevi Genomic MedicineFor profit1112012
BaxaltaFor profit1012007
Kuros Biosurgery AGFor profit1112007
Tel Aviv UniversityAcademic/Hospital1012012
4 organizations
Page 1 / 1